Rachel has welcomed the announcement that NHS England has secured a deal with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines.
This is an issue Rachel has been campaigning on after Nicco Andrews, from Redditch, attended one of Rachel’s surgery to tell his story about living with cystic fibrosis. Nicco was fortunate enough to be selected to take part in the Orkambi drug trial.
At Rachel’s surgery, Nicco spoke to her about the positive impact the drug was having on his health and his life. He then called for more sufferers to have access to this life-changing drug.
After hearing Nicco’s story, Rachel backed his calls and met with the Health Secretary and raised Nicco’s story in the House of Commons.
And last week it was announced by the Health Secretary, Matt Hancock, that NHS England will now have full access to Orkambi, Symkevi and Kalydeco, and around 5000 people may now take up these treatments. There is no cap on patient numbers, and each and every patient in England who might benefit can now get these treatments, free on the NHS. Clinicians will be able to begin prescribing these drugs within 30 days.
In welcoming the announcement, Rachel said:
“This is absolutely fantastic news which will change the lives of people across this country, including Nicco’s.
“I’d like to pay tribute to Nicco for meeting with me to share his story. He knew how lucky he was to be part of the Orkambi drug trial and he wanted everyone living with cystic fibrosis to have the same access to these life-changing drugs. They now will thanks to the efforts of Nicco and campaign groups across the country.”